The following symptoms may occasionally occur at the beginning of use: redness, mild transient stinging or burning sensations, and local pain. The following conditions were reported very rarely during clinical trials: hypergranulation and partial necrosis found only in a very limited area of the wound bed, but the causal relationship to CURIOSIN therapy has not been established.
View ADR Monitoring Form